A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway
Abstract: Almost all mutations of ITGA2B or ITGB3 identified in congenital macrothrombocytopenia induce constitutive activation of αIIbβ3. However, whether concomitant αIIbβ3 activation is essential for macrothrombocytopenia development remains unknown. Recently, we identified the β3(R760C) mutation...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Blood Vessels, Thrombosis & Hemostasis |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950327224000366 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841545497686310912 |
|---|---|
| author | Keiichi Nakata Keigo Akuta Takaya Endo Midori Koike Daisuke Motooka Daisuke Okuzaki Hisashi Kato Yoshiaki Tomiyama Naoki Hosen Hirokazu Kashiwagi |
| author_facet | Keiichi Nakata Keigo Akuta Takaya Endo Midori Koike Daisuke Motooka Daisuke Okuzaki Hisashi Kato Yoshiaki Tomiyama Naoki Hosen Hirokazu Kashiwagi |
| author_sort | Keiichi Nakata |
| collection | DOAJ |
| description | Abstract: Almost all mutations of ITGA2B or ITGB3 identified in congenital macrothrombocytopenia induce constitutive activation of αIIbβ3. However, whether concomitant αIIbβ3 activation is essential for macrothrombocytopenia development remains unknown. Recently, we identified the β3(R760C) mutation that does not induce αIIbβ3 activation in a patient with macrothrombocytopenia. The family study showed that macrothrombocytopenia with reduced expression of αIIbβ3 and glycoprotein IV (GPVI) appeared to be associated with patients heterozygous for β3(R760C). We generated β3(R760C) knockin (KI) mice and investigated the effects of the mutation on platelet/megakaryote biology. Macrothrombocytopenia was decreased to 76% and 40% of platelet counts in heterozygous (Hetero) and homozygous (Homo) KI mice, respectively, when compared with the wild-type mice. Platelet αIIbβ3 and GPVI expression were decreased in KI mice, and αIIbβ3 activation was not detected in nonstimulated KI platelets. Thus, the hetero KI mice reproduced the phenotype of the human participant, indicating that the β3(R760C) mutation is responsible for the macrothrombocytopenia. Platelet aggregation, agonist-induced JON/A binding, and P-selectin expression were impaired in KI mice. Platelet spreading on fibrinogen was also impaired in Homo mice with adenosine 5′-diphosphate or thrombin stimulation. Filopodia and lamellipodia formation was impaired in fibrinogen-adhered megakaryocytes of Homo mice with significantly impaired RhoA activation. Proplatelet formation in Homo mice was impaired with abnormal morphology. In addition, platelet life span was shortened in Homo mice. These data indicate that the β3(R760C) mutation impairs the inside-out and outside-in signaling of αIIbβ3, and abnormal actin rearrangement and impaired RhoA activation may play major roles in macrothrombocytopenia. |
| format | Article |
| id | doaj-art-43719f58e217442c81f48246b32eafda |
| institution | Kabale University |
| issn | 2950-3272 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Vessels, Thrombosis & Hemostasis |
| spelling | doaj-art-43719f58e217442c81f48246b32eafda2025-01-12T05:26:24ZengElsevierBlood Vessels, Thrombosis & Hemostasis2950-32722025-02-0121100036A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathwayKeiichi Nakata0Keigo Akuta1Takaya Endo2Midori Koike3Daisuke Motooka4Daisuke Okuzaki5Hisashi Kato6Yoshiaki Tomiyama7Naoki Hosen8Hirokazu Kashiwagi9Department of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Blood Transfusion, Osaka University Hospital, Suita, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Blood Transfusion, Osaka University Hospital, Suita, JapanGenome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, JapanGenome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Blood Transfusion, Osaka University Hospital, Suita, Japan; Correspondence: Hirokazu Kashiwagi, Department of Hematology and Oncology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, 565-0871, Japan;Abstract: Almost all mutations of ITGA2B or ITGB3 identified in congenital macrothrombocytopenia induce constitutive activation of αIIbβ3. However, whether concomitant αIIbβ3 activation is essential for macrothrombocytopenia development remains unknown. Recently, we identified the β3(R760C) mutation that does not induce αIIbβ3 activation in a patient with macrothrombocytopenia. The family study showed that macrothrombocytopenia with reduced expression of αIIbβ3 and glycoprotein IV (GPVI) appeared to be associated with patients heterozygous for β3(R760C). We generated β3(R760C) knockin (KI) mice and investigated the effects of the mutation on platelet/megakaryote biology. Macrothrombocytopenia was decreased to 76% and 40% of platelet counts in heterozygous (Hetero) and homozygous (Homo) KI mice, respectively, when compared with the wild-type mice. Platelet αIIbβ3 and GPVI expression were decreased in KI mice, and αIIbβ3 activation was not detected in nonstimulated KI platelets. Thus, the hetero KI mice reproduced the phenotype of the human participant, indicating that the β3(R760C) mutation is responsible for the macrothrombocytopenia. Platelet aggregation, agonist-induced JON/A binding, and P-selectin expression were impaired in KI mice. Platelet spreading on fibrinogen was also impaired in Homo mice with adenosine 5′-diphosphate or thrombin stimulation. Filopodia and lamellipodia formation was impaired in fibrinogen-adhered megakaryocytes of Homo mice with significantly impaired RhoA activation. Proplatelet formation in Homo mice was impaired with abnormal morphology. In addition, platelet life span was shortened in Homo mice. These data indicate that the β3(R760C) mutation impairs the inside-out and outside-in signaling of αIIbβ3, and abnormal actin rearrangement and impaired RhoA activation may play major roles in macrothrombocytopenia.http://www.sciencedirect.com/science/article/pii/S2950327224000366 |
| spellingShingle | Keiichi Nakata Keigo Akuta Takaya Endo Midori Koike Daisuke Motooka Daisuke Okuzaki Hisashi Kato Yoshiaki Tomiyama Naoki Hosen Hirokazu Kashiwagi A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway Blood Vessels, Thrombosis & Hemostasis |
| title | A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway |
| title_full | A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway |
| title_fullStr | A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway |
| title_full_unstemmed | A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway |
| title_short | A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway |
| title_sort | nonactivating itgb3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αiibβ3 rhoa pathway |
| url | http://www.sciencedirect.com/science/article/pii/S2950327224000366 |
| work_keys_str_mv | AT keiichinakata anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT keigoakuta anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT takayaendo anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT midorikoike anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT daisukemotooka anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT daisukeokuzaki anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT hisashikato anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT yoshiakitomiyama anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT naokihosen anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT hirokazukashiwagi anonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT keiichinakata nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT keigoakuta nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT takayaendo nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT midorikoike nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT daisukemotooka nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT daisukeokuzaki nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT hisashikato nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT yoshiakitomiyama nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT naokihosen nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway AT hirokazukashiwagi nonactivatingitgb3mutationintheb3cytoplasmicregioncausesmacrothrombocytopeniawithanimpairedaiibb3rhoapathway |